ASX - By Stock
|
PIQ |
Re:
Ann: Sonic Healthcare USA signs licence for PromarkerD in the US
|
|
bella44
|
78 |
34K |
10 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
78
|
34K
|
10
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Sonic Healthcare USA signs licence for PromarkerD in the US
|
|
bella44
|
78 |
34K |
14 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
78
|
34K
|
14
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: PromarkerD application for Australian MBS to be resubmitted
|
|
bella44
|
49 |
18K |
5 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
49
|
18K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: US update - PromarkerD licensing negotiations
|
|
bella44
|
30 |
14K |
8 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
30
|
14K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Letter of intent with Sonic Healthcare USA extended
|
|
bella44
|
24 |
8.5K |
4 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
24
|
8.5K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: CPT PLA reimbursement code approved in US for PromarkerD
|
|
bella44
|
42 |
18K |
12 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
42
|
18K
|
12
|
|
ASX - By Stock
|
PIQ |
Re:
CSL Connection
|
|
bella44
|
7 |
3.6K |
3 |
05/11/22 |
05/11/22 |
ASX - By Stock
|
7
|
3.6K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
CSL Connection
|
|
bella44
|
7 |
3.6K |
7 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
7
|
3.6K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
CSL Connection
|
|
bella44
|
7 |
3.6K |
3 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
7
|
3.6K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
CSL Connection
|
|
bella44
|
7 |
3.6K |
6 |
23/10/22 |
23/10/22 |
ASX - By Stock
|
7
|
3.6K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Relationship with Sonic looks strong
|
|
bella44
|
7 |
4.0K |
5 |
16/10/22 |
16/10/22 |
ASX - By Stock
|
7
|
4.0K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Relationship with Sonic looks strong
|
|
bella44
|
7 |
4.0K |
6 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
7
|
4.0K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Relationship with Sonic looks strong
|
|
bella44
|
7 |
4.0K |
3 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
7
|
4.0K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: New Oesophageal Cancer Diagnostic shows strong performance
|
|
bella44
|
4 |
2.2K |
8 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
4
|
2.2K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs binding LOI with Sonic Healthcare USA
|
|
bella44
|
56 |
22K |
1 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
56
|
22K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs binding LOI with Sonic Healthcare USA
|
|
bella44
|
56 |
22K |
1 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
56
|
22K
|
1
|
|
Charts
|
PIQ |
Re:
PIQ Chart
|
|
bella44
|
9 |
4.8K |
8 |
16/09/22 |
16/09/22 |
Charts
|
9
|
4.8K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Closing Trades
|
|
bella44
|
12 |
5.6K |
1 |
21/08/22 |
21/08/22 |
ASX - By Stock
|
12
|
5.6K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Closing Trades
|
|
bella44
|
12 |
5.6K |
3 |
21/08/22 |
21/08/22 |
ASX - By Stock
|
12
|
5.6K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Closing Trades
|
|
bella44
|
12 |
5.6K |
1 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
12
|
5.6K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics raises $8m in highly successful Placement
|
|
bella44
|
16 |
6.4K |
6 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
16
|
6.4K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics raises $8m in highly successful Placement
|
|
bella44
|
16 |
6.4K |
6 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
16
|
6.4K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
News: PIQ Proteomics International Laboratories Gets Firm Commitments To Raise A$8 Mln
|
|
bella44
|
2 |
738 |
3 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
2
|
738
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
8 |
3.3K |
3 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
8
|
3.3K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
8 |
3.3K |
4 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
8
|
3.3K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs binding LOI with Sonic Healthcare USA
|
|
bella44
|
56 |
22K |
2 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
56
|
22K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs binding LOI with Sonic Healthcare USA
|
|
bella44
|
56 |
22K |
9 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
56
|
22K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Suspension from Quotation
|
|
bella44
|
21 |
5.8K |
1 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
21
|
5.8K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Suspension from Quotation
|
|
bella44
|
21 |
5.8K |
1 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
21
|
5.8K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Suspension from Quotation
|
|
bella44
|
21 |
5.8K |
1 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
21
|
5.8K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
0 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
1 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
0 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
64
|
22K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
3 |
07/08/22 |
07/08/22 |
ASX - By Stock
|
64
|
22K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
1 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
64
|
22K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
3 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
64
|
22K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
4 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
64
|
22K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
bella44
|
64 |
22K |
8 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
64
|
22K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Clinical Utility Study demonstrates PromarkerD test benefits
|
|
bella44
|
11 |
3.4K |
3 |
03/08/22 |
03/08/22 |
ASX - By Stock
|
11
|
3.4K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Clinical Utility Study demonstrates PromarkerD test benefits
|
|
bella44
|
11 |
3.4K |
5 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
11
|
3.4K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Potential breakthrough blood test for endometriosis
|
|
bella44
|
5 |
2.3K |
6 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
5
|
2.3K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: June 2022 Quarterly Activities Report and Appendix 4C
|
|
bella44
|
10 |
3.9K |
7 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
10
|
3.9K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: June 2022 Quarterly Activities Report and Appendix 4C
|
|
bella44
|
10 |
3.9K |
3 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
10
|
3.9K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: June 2022 Quarterly Activities Report and Appendix 4C
|
|
bella44
|
10 |
3.9K |
10 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
10
|
3.9K
|
10
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Investor Presentation
|
|
bella44
|
9 |
4.1K |
4 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
9
|
4.1K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Endometriosis clinical validation study readout positive
|
|
bella44
|
8 |
3.7K |
3 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
8
|
3.7K
|
3
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics secures licence to oesophageal cancer biomarkers
|
|
bella44
|
8 |
3.7K |
9 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
8
|
3.7K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics secures licence to oesophageal cancer biomarkers
|
|
bella44
|
8 |
3.7K |
6 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
8
|
3.7K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Study shows PromarkerD also predicts late-stage renal issues
|
|
bella44
|
21 |
7.9K |
5 |
13/06/22 |
13/06/22 |
ASX - By Stock
|
21
|
7.9K
|
5
|
|